Tumoroid guided Drug Testing and Cancer Therapy
Ole Thastrup CEO and co-founder of 2cureX. Ole is also Professor and Head of Dept. Drug design & Pharmacology (Univ. Copenhagen). Prior to 2cureX Ole was Head of Carlsberg Biosector where he was responsible for Carlsberg's biomedical research. Before that he was the scientific founder and Chief Scientific Officer of BioImage A/S (now Thermo Fischer BioImage) that was spun-out of Novo Nordisk A/S.
Timm Jessen CBO and co-founder of 2cureX, started his commercial career with Hoechst (pre-clinical discovery) where he became Steering Committee member of Hoechst's strategic collaborations. Subsequently Timm Jessen became CSO and COO of EvotecOAI. He was instrumental for Evotec OAI's strategic move into proprietary discovery programs.
Grith Hagel Head of Project Management and co-founder of 2cureX. She has a comprehensive experience in developing and running drug screening campaigns. She is the inventor of several patents on advanced cell-based, high throughput screening technologies. Grith Hagel was co-founder of BioImage.